2nd Quarter - Termination

RICCHETTI INCORPORATED for EAGLE PHARMACEUTICALS, INC.

Firm
Client
Income
$40,000
Expenses
—
Terminated
Jun 1, 2021

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Reimbursement policies for 505(b)(2) approved drugs; Drug pricing and Medicare and Medicaid reimbursement

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues related to pharmaceutical industry, generally

LobbyistCovered position, as disclosed
JEFF RICCHETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.